This study examined the mechanisms by which H 2 S modulates coronary microvascular resistance and myocardial perfusion at rest and in response to cardiac ischemia. Experiments were conducted in isolated coronary arteries and in open-chest anesthetized dogs. We found that the H 2 S substrate L-cysteine (1-10 mM) did not alter coronary tone of isolated arteries in vitro or coronary blood flow in vivo. In contrast, intracoronary (ic) H 2 S (0.1-3 mM) increased coronary flow from 0.49 ± 0.08 to 2.65 ± 0.13 ml/min/g (P□0.001). This increase in flow was unaffected by inhibition of Kv channels with 4-aminopyridine (P=0.127) but was attenuated (0.23 ± 0.02 to 1.13 ± 0.13 ml/min/g) by the K ATP channel antagonist glibenclamide (P□0.001). Inhibition of NO synthesis (L-NAME) did not attenuate coronary responses to H 2 S. Immunohistochemistry revealed expression of cystathionine gamma-lyase (CSE), an endogenous H 2 S enzyme, in myocardium. Inhibition of CSE with β-cyano-L-alanine (10 µM) had no effect on baseline coronary flow or responses to a 15 sec coronary occlusion (P=0.82). These findings demonstrate that exogenous H 2 S induces potent, endothelial-independent dilation of the coronary microcirculation predominantly through the activation of K ATP channels, however, our data do not support a functional role for endogenous H 2 S in the regulation of coronary microvascular resistance.
Introduction
The endogenous gasotransmitter hydrogen sulfide (H 2 S) is known to exert a variety of effects on the cardiovascular system (14, 37, 41) . In particular, H 2 S has been shown to be a vasodilator in multiple vascular beds (10, 17, 22, 39, 44, 45) and to influence the physiologic regulation of vascular tone (15, 40) and blood pressure (44, 46) . Other studies have also demonstrated that H 2 S acts as a negative inotrope (14, 37, 41) . Thus, H 2 S could protect the heart from ischemic injury by mediating the balance between myocardial oxygen delivery and metabolism. The potential cardioprotective actions of H 2 S are supported by data indicating that exogenous administration of H 2 S donors protects against a loss of contractile function and diminishes myocardial infarct size/necrosis in animal models of ischemia reperfusion injury (6, 19, 32, 47) . Although these protective effects are associated with improvements in coronary endothelial dependent and independent microvascular reactivity (32), the direct effects of H 2 S on the coronary circulation have not been specifically examined.
This investigation was designed to elucidate the mechanisms by which H 2 S influences myocardial perfusion and to define the role of H 2 S in the regulation of coronary microvascular resistance at rest and in response to a brief episode of cardiac ischemia. Experiments tested the hypothesis that H 2 S induces dose-dependent coronary vasodilation via endothelial-dependent production of nitric oxide (NO) (1, 11) , and that endogenous production of H 2 S contributes to the control of coronary blood flow in normal and/or ischemic hearts. Additional studies were also conducted to examine whether H 2 S elicits increases in coronary blood flow through activation of ATP-sensitive K + (K ATP ) channels or voltage-dependent K + (K v ) channels, both of which have been shown to modulate vascular responses to H 2 S in non-coronary vascular beds (28, 36, 45, 49) and in response to myocardial ischemia (5, 7, 12) . Findings from this investigation provide novel insight in to the mechanisms and functional significance of H 2 S in the regulation of coronary blood flow in vivo. 
Methods

Immunohistochemistry
Immunohistochemical (IHC) analyses were performed in conjunction with Indiana University Health Pathology Laboratory (Indianapolis, IN). Briefly, liver and cardiac tissues were harvested immediately post mortem, rinsed in saline and transferred to 10% formalin. Formalin fixed tissues were then exposed to primary IgG antibodies against cystathionine β-synthase (CBS) and cystathionine γ-lyase (CSE) at manufacturer recommended concentrations (Sigma Aldrich, St. Louis, Missouri). Slides were imaged at 10× magnification on a Nikon Eclipse 80i microscope and images captured with a Nikon DS-Fi1 and associated Nikon Elements software.
Isometric tension studies
Canine hearts were excised upon sacrifice and the aorta cannulated to perfuse the coronary tree with 4°C, Ca 2+ -free Krebs solution (131.5 mM NaCl, 5 mM KCl, 1.2 mM NaH 2 PO 4 , 1.2 mM MgCl 2 , 25 mM NaHCO 3 , 10 mM glucose) in order to rinse the excised heart of blood and blood proteins. After perfusion, coronary arteries were grossly dissected from the heart, and further isolated from surrounding myocardium and adventitia using a dissecting microscope. Following adventitial removal, arteries were cut into 3 mm rings and mounted in water-jacketed organ baths filled with a Ca 2+ -containing Krebs solution (131.5 mM NaCl, 5 mM KCl, 1.2 mM NaH 2 PO 4 , 1.2 mM MgCl 2 , 25 mM NaHCO 3 , 10 mM glucose, 4 mM CaCl 2 ) at 37°C. Optimal length (passive tension) was assessed by contractions of isolated arteries to 60 mM KCl. Passive tension was increased in gram increments until there was <10% change in active tension development to 60 mM KCl (typical optimal passive tension equaled ~4 g). Once optimal passive tension was obtained, arteries were then pre-constricted with 1 µM U46619 and stimulated with either NaHS (1-10 mM) or the H 2 S substrate Lcysteine (1-10 mM). Changes in vascular tone were measured as a percent change from maximal tension developed in response to 1 µM U46619.
Surgical preparation
Dogs were initially sedated with morphine (3 mg/kg, subcutaneously) and anesthetized with α-chloralose (100 mg/kg, intravenously). The animals were then intubated and mechanically ventilated (Harvard respirator) with oxygen-supplemented room air. A catheter was placed into the thoracic aorta via the right femoral artery to measure aortic blood pressure and heart rate. The left femoral artery was catheterized to supply blood to an extracorporeal perfusion system used to perfuse the left anterior descending (LAD) artery at a controlled pressure (100 mmHg). A catheter was also inserted into the right femoral vein for injection of supplemental anesthetic, heparin and sodium bicarbonate. Arterial blood gases were analyzed periodically throughout the experimental protocol and adjustments were made as needed to maintain blood gas parameters within normal physiological limits. A left lateral thoracotomy was performed to expose the heart, and the LAD was isolated distal to its first major diagonal branch. Following heparin administration (500 U/kg, intravenously), the LAD was cannulated with a stainless steel cannula connected to an extracorporeal perfusion system. Coronary perfusion pressure (CPP) was regulated by a servo-controlled roller pump, held constant at 100 mmHg. Coronary blood flow was continuously measured by an inline Transonic Systems flow transducer (Ithaca, NY, USA). Data were continuously recorded on IOX data acquisition software from Emka Technologies (Falls Church, VA, USA).
Experimental Protocol
Following coronary cannulation, hemodynamic parameters were allowed to stabilize for 30 min. Basal coronary blood flow and hematocrit were then determined, and based on these parameters, an aqueous solution of NaHS was infused into the LAD perfusion line at controlled rates in order to achieve coronary plasma NaHS concentrations of 100µM, 300 µM, 1 mM, and 3mM. Animals were also subjected to an L-cysteine dose response curve (100 µM, 300 µM, 1 mM and 3 mM). Coronary flow responses as well as heart rate and blood pressure were monitored throughout the course of the dose response curves. Following a 15 min washout period, animals were then subjected to an identical NaHS dose response curve in the presence of the NO synthase inhibitor L-NG-Nitroarginine methyl ester (L-NAME, ~35 µg/ml, ic), the general K v channel blocker 4-aminopyridine (4AP, 0.3mM, ic) or the K ATP channel inhibitor glibenclamide (3mg/kg, iv). In a subset of animals (n = 3), coronary reactive hyperemic responses were measured following a 15 second occlusion of the LAD in the absence and presence of the CSE enzyme inhibitor β-cyano Lalanine (BCA, 10µM, ic). Hyperemic responses were measured until coronary flow reached baseline values. All drugs (Sigma Aldrich, St Louis, MO, USA) with the exception of glibenclamide (dissolved in equal parts of ethanol, propylene glycol, 1N NaOH) were dissolved in saline and infused in to the coronary perfusion line. Data on the systemic hemodynamic effects of each of these drugs are provided in Table 1 .
Statistical analyses
Data are presented as mean ± SE. Statistical comparisons were made by a one-way or twoway repeated measures analysis of variance (ANOVA) as appropriate (Sigma Plot 11.0 Software). If statistical differences (P < 0.05) in these analyses were noted, a StudentNewman-Keuls multiple comparison test was performed. Reactive hyperemic volumes were calculated as area under the curve using Prism software (GraphPad Software).
Results
Tissue Immunohistochemistry
Consistent with previous findings (2, 16), liver tissue sections stained positive for both of the H 2 S producing enzymes cystathionine γ-lyase (CSE) ( Figure 1A ) and cystathionine β-synthase (CBS) (Figure 1B) . However, expression of these enzymes within liver vasculature was relatively modest (see inset). Left ventricular myocardial tissue also stained positive for CSE ( Figure 1C) and CBS ( Figure 1D) . However, CSE and CBS were not prominently expressed in the coronary vasculature (see inset).
Isometric Tension Studies
Isometric tension recordings were performed on isolated coronary artery rings preconstricted with the thromboxane A 2 mimetic U46619 (1 µM). In these pre-contracted rings, administration of the H 2 S substrate L-cysteine (1-10 mM; n = 3) tended to increase isometric tension ~15% (Figure 2A) while NaHS (1-10 mM; n = 3) tended to diminish active tension development ~5% (Figure 2B) . However, neither L-cysteine (P = 0.27) nor NaHS (P = 0.44) significantly altered coronary artery tension relative to U46619 treatment alone.
Effects of H 2 S on Coronary Blood Flow In Vivo
Intracoronary administration of L-cysteine (0.1-3.0 mM) had no effect on baseline coronary blood flow (Figure 2C) . In contrast, infusion of NaHS (n = 5) dose-dependently increased coronary blood flow from 0.49 ± 0.09 ml/min/g at baseline to 2.65 ± 0.15 ml/min/g at the highest (3 mM) concentration of NaHS ( Figure 2D ; P < 0.001). This vasodilator response was not significantly diminished by inhibition of NO synthase with L-NAME ( Figure 3A ; n = 3) or by blockade of K v channels with 4AP ( Figure 3B ; n = 3). However, administration of the K ATP channel antagonist glibenclamide significantly impaired coronary vasodilation to 3mM H 2 S by ~ 70% (P < 0.001) (Figure 3B ; n = 5).
Inhibition of H 2 S Producing Enzyme CSE
Administration of the CSE enzyme inhibitor BCA (10 µM; n = 3) had no effect on baseline hemodynamic parameters ( Table 1 ). The effect of CSE inhibition on the coronary blood flow response to a 15 sec coronary artery occlusion (i.e. coronary reactive hyperemia) is shown in Figure 4 . BCA did not significantly affect the reactive hyperemic response as evidenced by no alterations in the peak vasodilatory response, flow volume of repayment or in the repayment of the coronary flow debt following the inhibition of CSE (P = 0.82) ( Table 2) .
Discussion
This study was designed to delineate the mechanisms by which H 2 S modulates coronary microvascular resistance and myocardial perfusion at rest and in response to transient cardiac ischemia. The major novel findings of the investigation include: 1) prominent expression of the H 2 S producing enzymes CBS and CSE in canine myocardium; 2) infusion of the key H 2 S substrate L-cysteine failed to significantly alter coronary vascular tone of isolated conduit arteries in vitro or microvessels in vivo; 3) intracoronary administration of H 2 S dose-dependently increases coronary blood flow (~ 5 fold) via activation of K ATP channels; 4) H 2 S mediated coronary vasodilation occurs independent of endothelial NO production or K v channel activation and is largely absent in conduit coronary arteries; 5) inhibition of endogenous CSE has no effect on the regulation of coronary blood flow at rest or in response to a brief coronary artery occlusion. Taken together, these findings indicate that exogenous H 2 S induces potent dilation of the canine coronary microcirculation predominantly through a K ATP channel dependent (NO independent) mechanism. However, our data support no functional role for endogenous H 2 S in the regulation of baseline coronary resistance or ischemic coronary vasodilation.
Functional expression of H 2 S producing enzymes in canine hearts
Our IHC studies demonstrate the prominent expression the H 2 S producing enzymes (CBS and CSE) in canine myocardium (Figure 1) . This finding is consistent with other studies which have documented the presence of CSE in rat and mouse liver and cardiac tissue (14, 16, 34, 46) , and expression of CBS in rodent hearts (9, 35) . IHC also revealed relatively low levels of CSE and CBS expression in the liver and cardiac microcirculation ( Figure 1C &  1D) ; which is consistent with little/no effect of the H 2 S substrate L-cysteine on tone of isolated coronary arteries (Figure 2A) or on coronary blood flow in vivo ( Figure 2C) . This lack of a coronary response to L-cysteine is in contrast with the recent findings of Leffler et al. who documented dose-dependent dilation to L-cysteine in cerebral pial arterioles in newborn swine (22); i.e. differences in the functional relevance of endogenous H 2 S production likely exist between the cerebral and coronary circulation.
Although H 2 S is known to be a vasodilator in a variety of vascular beds (10, 17, 31, 36, 49) , primarily in the cerebral circulation (22, 23, 25, 26, 39) , no study has directly examined coronary vasodilation in response to NaHS administration in vivo. We found that NaHS significantly increased coronary blood flow in a concentration dependent manner ( Figure  2D) . Interestingly, our findings indicate marked regional differences in coronary conduit vs. microvascular responsiveness to H 2 S as isolated coronary arteries responded only ~5% to 3 mM NaHS while coronary flow increased ~500% in response to the same concentration of NaHS.
Mechanism of H 2 S-mediated coronary vasodilation
Earlier studies in peripheral arteries suggest that H 2 S mediated dilation occurs via an endothelial-dependent mechanism (10, 48) that converges on the activation of smooth muscle K ATP (22, 25, 28, 29, 49, 50) and/or K Ca channels (17, 26) . However, the pathways responsible for the effects of H 2 S in the coronary circulation have not been delineated. In the current study, we found that intracoronary administration H 2 S (plasma concentration 3 mM) induced an ~5-fold increase in coronary blood flow (Figure 2D ). This increase in coronary flow is not related to endothelial-production of NO as administration of the NOS inhibitor L-NAME, at a dose we previously demonstrated to attenuate NO-mediated coronary vasodilation in dogs (5, 20) , did not diminish the coronary response to H 2 S (Figure 3A) . Infusion of the voltage-dependent K + channel antagonist 4-aminopyridine (4AP) also had no effect on H 2 S mediated coronary vasodilation ( Figure 3B) . However, inhibition of K ATP channels with glibenclamide significantly reduced the increase in coronary blood flow to H 2 S by nearly 70% (Figure 3B) . Therefore, our findings demonstrate that exogenous H 2 S acts as a potent endothelial-independent vasodilator in the coronary circulation predominantly via activation of smooth muscle K ATP channels. Given the prominent role of K v and K ATP channels in the regulation of coronary blood flow (3, 4, 13, 43) , and the relatively modest effect of K Ca channel inhibition on coronary responses in vivo (7, 8, 21) we elected to focus the present studies on H 2 S mediated activation of coronary K v and K ATP channels. Since earlier studies in other vascular beds have documented a role for K Ca channels in H 2 S-induced dilation (18, 24, 27, 42) , further systematic experiments are needed to specifically examine the contribution of specific K Ca channels (BK Ca , IK Ca , SK Ca ) to H 2 S mediated increases in coronary blood flow.
Role of endogenous H 2 S in control of coronary blood flow
As outlined above, the lack of a coronary response to the H 2 S substrate L-cysteine ( Figure  2) does not support an active role for endogenous H 2 S in the regulation of coronary microvascular resistance. However, alterations in the physiologic state of the myocardium, such as ischemia, have been shown to increase endogenous production of H 2 S and limit myocardial ischemia-reperfusion injury (38) . In order to examine the role of H 2 S in ischemic coronary vasodilation, coronary reactive hyperemia studies were conducted in the absence and presence of the CSE inhibitor BCA (30, 33) . Findings from these experiments indicate that 10 µM BCA, an effective dose capable of inhibiting liver H 2 S synthesizing activity (30) , had no effect on baseline coronary blood flow ( Table 1) or on any aspect of the coronary reactive hyperemic response (Figure 4) ; i.e. peak vasodilator response or the overall debt to repayment ratio ( Table 2) . Therefore, although there is evidence to support a role for endogenous H 2 S in mitigating myocardial ischemia-reperfusion injury (19, 32, 38, 51) , there are little/no data to support that endogenous H 2 S is an active regulator of coronary vasomotor tone at rest or following a brief episode of myocardial ischemia.
Conclusions
Findings from this investigation are the first to show that exogenous H 2 S induces potent, endothelial NO-independent dilation of the canine coronary microcirculation, predominantly through the activation of K ATP channels. Despite the pronounced effects of exogenous H 2 S, our data do not support a functional role for endogenous H 2 S in the regulation of baseline coronary resistance or ischemic coronary vasodilation. Such findings do not negate prior studies regarding the cardioprotective effects of endogenous H 2 S in the ischemic heart (38), but rather indicate that H 2 S-related improvements in cardiac function and ischemic injury are not mediated by alterations in myocardial perfusion per se. Therefore, although exogenous H 2 S demonstrates the capacity for robust coronary dilator responses, there was no demonstrable physiologic role for H 2 S as a coronary signaling molecule in this study. Representative immunohistochemistry showing expression of the H 2 S producing enzyme cystathionine γ-lyase (CSE) CSE in liver (A) and cardiac (C) tissue samples. Positive staining for the H 2 S producing enzyme cystathionine β-synthase (CBS) in liver (B) and heart (D). Insets: Magnification of microvessels show modest staining for both CSE and CBS in liver and cardiac tissue samples. Representative isometric tension recordings show modest effects of L-cysteine (n=3) (A) and NaHS (n=3) (B) on tension of isolated coronary artery rings pre-constricted with U46619. In-vivo intracoronary infusion of L-cysteine had no effect on basal coronary blood flow (C) while intracoronary infusion of NaHS significantly augmented coronary flow at plasma concentrations >300 µM (D). Inhibition of NO synthase with L-Name produced a modest increase the coronary blood flow response to intracoronary NaHS (n=3) (A). Coronary vasodilation to NaHS was unaffected by the inhibition of voltage-dependent K + channels with 4-AP (n=3) while blockade of K ATP channels with glibenclamide (n=5) markedly reduced NaHS-induced dilation in the coronary circulation. # P < 0.05; * P < 0.001. Inhibition of the H 2 S producing enzyme cystathionine γ-lyase (CSE) with β-cyano-L-alanine (BCA) (n=3) did not significantly alter the coronary blood flow response to a 15 sec coronary artery occlusion.
